List of works - Jane Davies

'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020

scientific article published on 07 March 2020

Airway remodelling and its relationship to inflammation in cystic fibrosis ⬇️

scientific article published on October 1, 2010

Basic science for the chest physician:Pseudomonas aeruginosaand the cystic fibrosis airway: Figure 1 ⬇️

scientific article published on March 1, 2012

Building global development strategies for cf therapeutics during a transitional cftr modulator era

scientific article published on 07 June 2020

Clinical Trials of Novel Treatments for Cystic Fibrosis

scientific article

Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential

scientific article published in September 2017

Combination antifungal therapy for Scedosporium species in cystic fibrosis

scientific article published on 27 April 2020

Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications

scientific article

Cystic Fibrosis: therapies targeting specific gene defects ⬇️

scientific article published on 09 May 2012

Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function ⬇️

scientific article published on September 16, 2010

Cystic fibrosis: to ion transport and beyond ⬇️

scientific article published on 01 November 2010

Design of Gene Therapy Trials in CF Patients ⬇️

scientific article published on January 1, 2011

Distal 10q trisomy syndrome with unusual cardiac and pulmonary abnormalities ⬇️

scientific article published on January 1, 1998

Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis ⬇️

scientific article published on October 18, 2011

Evaluation of a Multiple Breath Nitrogen Washout system in Children

scientific article published on 21 May 2020

Gene therapy for the treatment of cystic fibrosis ⬇️

scientific article published on May 29, 2012

Highlights of the North American Cystic Fibrosis Conference 2011 ⬇️

scientific article published on June 1, 2012

Impaired innate interferon induction in severe therapy resistant atopic asthmatic children

scientific article published on 05 December 2012

Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis

scientific article published on 24 January 2008

Ivacaftor in Infants Aged 4 to <12 Months With Cystic Fibrosis and a Gating Mutation: Results of a 2-Part Phase 3 Clinical Trial

scientific article published on 07 October 2020

Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations

scientific article published on 9 July 2015

Predicting the Future of Cystic Fibrosis Lung Disease: Gene Expression Holds Some of the Answers

scientific article published on 01 May 2018

Prospects for gene therapy for cystic fibrosis ⬇️

scientific article published on July 1, 1998

Prospects for gene therapy in lung disease ⬇️

scientific article published on June 1, 2001

Pseudomonas aeruginosa in cystic fibrosis: Pathogenesis and new treatments ⬇️

scientific article published on November 1, 2011

Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

scientific article

Response of Pseudomonas aeruginosa to the innate immune system-derived oxidants hypochlorous acid and hypothiocyanous acid

scientific article published on 26 October 2020

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.

scientific article

The clinical use of rhDNAse ⬇️

scientific article published on January 1, 1997

The journey of a thousand miles: Table 1– ⬇️

scientific article published on January 1, 2011

Use of cough swabs in a cystic fibrosis clinic ⬇️

scientific article published on November 1, 2001

List of works by Jane Davies

'Go for it, dream big, work hard and persist': A message to the next generation of CF leaders in recognition of International Women's Day 2020

Airway remodelling and its relationship to inflammation in cystic fibrosis ⬇️

Basic science for the chest physician:Pseudomonas aeruginosaand the cystic fibrosis airway: Figure 1 ⬇️

Building global development strategies for cf therapeutics during a transitional cftr modulator era

Clinical Trials of Novel Treatments for Cystic Fibrosis

Clinical trial research in focus: ensuring new cystic fibrosis drugs fulfil their potential

Combination antifungal therapy for Scedosporium species in cystic fibrosis

Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications

Cystic Fibrosis: therapies targeting specific gene defects ⬇️

Cystic fibrosis and survival to 40 years: a study of cystic fibrosis transmembrane conductance regulator function ⬇️

Cystic fibrosis: to ion transport and beyond ⬇️

Design of Gene Therapy Trials in CF Patients ⬇️

Distal 10q trisomy syndrome with unusual cardiac and pulmonary abnormalities ⬇️

Distinct patterns of inflammation in the airway lumen and bronchial mucosa of children with cystic fibrosis ⬇️

Evaluation of a Multiple Breath Nitrogen Washout system in Children

Gene therapy for the treatment of cystic fibrosis ⬇️

Highlights of the North American Cystic Fibrosis Conference 2011 ⬇️

Impaired innate interferon induction in severe therapy resistant atopic asthmatic children

Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and non-cystic fibrosis bronchiectasis

Ivacaftor in Infants Aged 4 to <12 Months With Cystic Fibrosis and a Gating Mutation: Results of a 2-Part Phase 3 Clinical Trial

Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations

Predicting the Future of Cystic Fibrosis Lung Disease: Gene Expression Holds Some of the Answers

Prospects for gene therapy for cystic fibrosis ⬇️

Prospects for gene therapy in lung disease ⬇️

Pseudomonas aeruginosa in cystic fibrosis: Pathogenesis and new treatments ⬇️

Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and persistence

Response of Pseudomonas aeruginosa to the innate immune system-derived oxidants hypochlorous acid and hypothiocyanous acid

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study.

The clinical use of rhDNAse ⬇️

The journey of a thousand miles: Table 1– ⬇️

Use of cough swabs in a cystic fibrosis clinic ⬇️